CVRx, Inc. (CVRX)

7.31 -0.48 (-6.16%) At close: 04:00PM EDT

CVRx, Inc.

9201 West Broadway Avenue
Suite 650
Minneapolis, MN 55445
United States
763 416 2840
https://www.cvrx.com

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 200

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Kevin Hykes	President, CEO & Director	37.06k	N/A	1966
Mr. Jared Oasheim	Chief Financial Officer	576.72k	N/A	1984
Mr. Paul Verrastro	Chief Marketing & Strategy Officer	598.97k	N/A	1963
Mr. Paul Pignato	Vice President of Operations	N/A	N/A	N/A
Ms. Jonelle R. Burnham	Vice President & General Counsel	N/A	N/A	1971
Mr. Craig Palmer	Senior Vice President of US Sales	N/A	N/A	1977

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. The company offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure with reduced ejection fraction or systolic heart failure. It sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, and internationally. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.

Corporate governance

CVRx, Inc.’s ISS governance QualityScore as of 1 May 2024 is 10. The pillar scores are Audit: 9; Board: 10; Shareholder rights: 8; Compensation: 9.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.